156 related articles for article (PubMed ID: 21554263)
21. Beta(2)-microglobulin as a negative growth regulator of myeloma cells.
Min R; Li Z; Epstein J; Barlogie B; Yi Q
Br J Haematol; 2002 Aug; 118(2):495-505. PubMed ID: 12139738
[TBL] [Abstract][Full Text] [Related]
22. Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.
Sasaki T; Ravindranath MH; Terasaki PI; Freitas MC; Kawakita S; Jucaud V
Int J Cancer; 2014 Apr; 134(7):1558-70. PubMed ID: 24105714
[TBL] [Abstract][Full Text] [Related]
23. Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays.
Visentin J; Guidicelli G; Couzi L; Merville P; Lee JH; Di Primo C; Taupin JL
Hum Immunol; 2016 Nov; 77(11):1048-1054. PubMed ID: 26902993
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies specific for human IgM Fc receptor inhibit ligand-binding activity.
Kubagawa Y; Honjo K; Kang DW; Kubagawa H
Monoclon Antib Immunodiagn Immunother; 2014 Dec; 33(6):393-400. PubMed ID: 25545208
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies directed against chicken β2-microglobulin developed with a synthesized peptide.
Yu C; Liu Q; Gao W; Qian K; Mei M; Shao HX; Wu GH; Jin WJ; Qin AJ
Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):205-10. PubMed ID: 23750479
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.
Williams EL; Tutt AL; Beers SA; French RR; Chan CH; Cox KL; Roghanian A; Penfold CA; Butts CL; Boross P; Verbeek JS; Cragg MS; Glennie MJ
J Immunol; 2013 Oct; 191(8):4130-40. PubMed ID: 24026082
[TBL] [Abstract][Full Text] [Related]
28. Altered antigenicity of human monoclonal antibodies derived from human-mouse heterohybridomas.
Kan-Mitchell J; Andrews KL; Gallardo D; Mitchell MS
Hybridoma; 1987 Apr; 6(2):161-72. PubMed ID: 3552958
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal IgM rheumatoid factors generated from synovial B cells of rheumatoid arthritis patients react with beta 2-microglobulin. Monoclonal RF react with beta 2m.
Williams RC; Malone CC; Kenny T; Robbins D
Autoimmunity; 1993; 16(2):103-14. PubMed ID: 8180316
[TBL] [Abstract][Full Text] [Related]
30. Identification of a human monoclonal natural IgM antibody that recognizes early apoptotic cells and promotes phagocytosis.
Kim J
Hybridoma (Larchmt); 2010 Aug; 29(4):275-81. PubMed ID: 20715985
[TBL] [Abstract][Full Text] [Related]
31. Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma.
Timm MM; Kimlinger TK; Haug JL; Kline MP; Greipp PR; Rajkumar SV; Kumar SK
Leukemia; 2006 Oct; 20(10):1863-9. PubMed ID: 16932343
[TBL] [Abstract][Full Text] [Related]
32. Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies.
Rudich SM; Winchester R; Mongini PK
J Exp Med; 1985 Oct; 162(4):1236-55. PubMed ID: 2413155
[TBL] [Abstract][Full Text] [Related]
33. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
Moshitzky S; Kukulansky T; Haimovich J; Hollander N
Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
[TBL] [Abstract][Full Text] [Related]
34. Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.
Kuroki M; Yamada H; Shibaguchi H; Hachimine K; Hirose Y; Kinugasa T; Ishida I; Kuroki M
Anticancer Res; 2005; 25(6A):3733-9. PubMed ID: 16302733
[TBL] [Abstract][Full Text] [Related]
35. Circulating natural IgM antibodies and their corresponding human cord blood cell-derived Mabs specifically combat the Tat protein of HIV.
Rodman TC; Lutton JD; Jiang S; Al-Kouatly HB; Winston R
Exp Hematol; 2001 Aug; 29(8):1004-9. PubMed ID: 11495706
[TBL] [Abstract][Full Text] [Related]
36. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
Chaouchi N; Vazquez A; Galanaud P; Leprince C
J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
[TBL] [Abstract][Full Text] [Related]
37. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
38. Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide.
Burns T; Zhong Z; Steinitz M; Pirofski LA
Infect Immun; 2003 Dec; 71(12):6775-83. PubMed ID: 14638763
[TBL] [Abstract][Full Text] [Related]
39. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.
Racila E; Scheuermann RH; Picker LJ; Yefenof E; Tucker T; Chang W; Marches R; Street NE; Vitetta ES; Uhr JW
J Exp Med; 1995 Apr; 181(4):1539-50. PubMed ID: 7535341
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG.
Shitara K; Fujiwara K; Igarashi S; Ohta S; Furuya A; Nakamura K; Koike M; Hanai N
J Immunol Methods; 1994 Feb; 169(1):83-92. PubMed ID: 8133075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
